315 related articles for article (PubMed ID: 8568827)
21. gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates.
Galivan J; Inglese J; McGuire JJ; Nimec Z; Coward JK
Proc Natl Acad Sci U S A; 1985 May; 82(9):2598-602. PubMed ID: 2581252
[TBL] [Abstract][Full Text] [Related]
22. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activities of tricyclic conformationally restricted tetrahydropyrido annulated furo[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases.
Gangjee A; Elzein E; Queener SF; McGuire JJ
J Med Chem; 1998 Apr; 41(9):1409-16. PubMed ID: 9554874
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
25. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
Tsukamoto T; Haile WH; McGuire JJ; Coward JK
Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
[TBL] [Abstract][Full Text] [Related]
26. Interaction of D, L-erythro- and D,L-threo-gamma-fluoromethotrexate with human leukemia cell dihydrofolate reductase.
McGuire JJ; Haile WH; Coward JK
Biochem Pharmacol; 1989 Dec; 38(23):4321-5. PubMed ID: 2597202
[TBL] [Abstract][Full Text] [Related]
27. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
Balińska M
Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of classical and nonclassical, partially restricted, linear, tricyclic 5-deaza antifolates.
Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
J Med Chem; 2002 Nov; 45(23):5173-81. PubMed ID: 12408727
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of novel fluorinated methotrexate derivatives for application to rheumatoid arthritis treatment.
Kokuryo Y; Kawata K; Nakatani T; Kugimiya A; Tamura Y; Kawada K; Matsumoto M; Suzuki R; Kuwabara K; Hori Y; Ohtani M
J Med Chem; 1997 Sep; 40(20):3280-91. PubMed ID: 9379448
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
31. Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro.
Fry DW; Yalowich JC; Goldman ID
J Biol Chem; 1982 Feb; 257(4):1890-6. PubMed ID: 6120169
[No Abstract] [Full Text] [Related]
32. Deaza analogs of folic acid as antitumor agents.
Kisliuk RL
Curr Pharm Des; 2003; 9(31):2615-25. PubMed ID: 14529545
[TBL] [Abstract][Full Text] [Related]
33. Lipoamino acid conjugates of methotrexate with antitumor activity.
Pignatello R; Jansen G; Kathmann I; Puglisi G; Toth I
J Pharm Sci; 1998 Mar; 87(3):367-71. PubMed ID: 9523991
[TBL] [Abstract][Full Text] [Related]
34. Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductase.
Abraham A; McGuire JJ; Galivan J; Nimec Z; Kisliuk RL; Gaumont Y; Nair MG
J Med Chem; 1991 Jan; 34(1):222-7. PubMed ID: 1992121
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and biological properties of methotrexate analogs containing D-glutamic acid or D-erythro, threo-4-fluoroglutamic acid.
McGuire JJ; Bolanowska WE; Coward JK; Sherwood RF; Russell CA; Felschow DM
Biochem Pharmacol; 1991 Nov; 42(12):2400-3. PubMed ID: 1684899
[No Abstract] [Full Text] [Related]
36. Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.
Graffner-Nordberg M; Marelius J; Ohlsson S; Persson A; Swedberg G; Andersson P; Andersson SE; Aqvist J; Hallberg A
J Med Chem; 2000 Oct; 43(21):3852-61. PubMed ID: 11052790
[TBL] [Abstract][Full Text] [Related]
37. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
Mareya SM; Sorrentino BP; Blakley RL
Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
[TBL] [Abstract][Full Text] [Related]
38. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
39. In vitro synthesis of alpha-carboxyl-linked folylpolyglutamates by an enzyme preparation from Escherichia coli.
Ferone R; Singer SC; Hunt DF
J Biol Chem; 1986 Dec; 261(35):16363-71. PubMed ID: 3536926
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
